The Mammalian ShcB and ShcC Phosphotyrosine Docking Proteins Function in the Maturation of Sensory and Sympathetic Neurons  by Sakai, Ryuichi et al.
Neuron, Vol. 28, 819–833, December, 2000, Copyright ª 2000 by Cell Press
The Mammalian ShcB and ShcC Phosphotyrosine
Docking Proteins Function in the Maturation
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effectors such as MAP kinase (MAPK) and phosphatidyl-Toronto, Ontario M5G 2C1
inosoitol 39 kinase (PI3K). In addition, Shc-associatedCanada
Grb2 can also recruit Gab2, a docking protein that di-4 Virology Division
rectly binds PI3K (Gu et al., 2000). Shc can also interactNational Cancer Center Research Institute
with the 59 inositol phosphatase SHIP (Liu et al., 1997)Tsukiji 5-1-1, Chuo-ku
and binds adaptins through a conserved CH1 motif, asTokyo 104-0045
well as SH3 proteins that recognize a proline-rich motifJapan
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indicate that Shc proteins may regulate multiple signal-Health Sciences
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Three mammalian Shc genes have been identified thatSummary
encode closely related proteins, ShcA (formerly Shc),
ShcB (Sli/SCK), and ShcC (Rai/N-Shc) (O’Bryan et al.,Shc proteins possess SH2 and PTB domains and serve
1996b; Pelicci et al., 1996; Nakamura et al., 1998). Thea scaffolding function in signaling by a variety of recep-
ShcA gene is broadly expressed in adult mice and en-tor tyrosine kinases. There are three known mamma-
codes three protein isoforms (p66, p52, and p46) thatlian Shc genes, of which ShcB and ShcC are primarily
differ only in their N-terminal sequences (Pelicci et al.,expressed in the nervous system. We have generated
1992). ShcA proteins bind a number of activated RTKs,null mutations in ShcB and ShcC and have obtained
including Ret and Trk family neurotrophin receptors,mice lacking either ShcB or ShcC or both gene prod-
through their PTB or SH2 domains (Stephens et al., 1994;ucts. ShcB-deficient animals exhibit a loss of peptider-
van der Geer et al., 1995; Lorenzo et al., 1997).
gic and nonpeptidergic nociceptive sensory neurons,
Unlike ShcA, ShcB expression is more strongly con-
which is not enhanced by additional loss of ShcC. Mice
fined to the nervous system, and ShcC appears to be
lacking both ShcB and ShcC exhibit a significant loss exclusively expressed in neural cells (O’Bryan et al.,
of neurons within the superior cervical ganglia, which 1996b; Pelicci et al., 1996; Nakamura et al., 1998). Within
is not observed in either mutant alone. The results the nervous system, both ShcB and ShcC mRNAs have
indicate that these Shc family members possess both been found in a wide range of structures in the adult
unique and overlapping functions in regulating neural brain (Pelicci et al., 1996; Nakamura et al., 1998), while
development and suggest physiological roles for neural ShcA mRNA expression is primarily confined to
ShcB/ShcC in TrkA signaling. the ventricular zone of the early embryonic brain (Conti
et al., 1997).
Introduction Although they are the predominant neuronal Shc iso-
forms, information concerning the roles of ShcB and
Activated receptor tyrosine kinases (RTKs) bind cyto- ShcC in neural cell function is limited. ShcC can bind
plasmic signaling proteins that possess phosphotyro- activated receptors, including the EGF receptor (EGFR)
sine (pTyr) recognition modules such as Src homology and Trk receptors, in a similar fashion to ShcA (O’Bryan
2 (SH2) or pTyr binding (PTB) domains (Pawson and et al., 1996a; Nakamura et al., 1998). Overexpression of
Scott, 1997). SH2 domains selectively recognize pTyr in the SH2 or PTB domains of ShcC can impair activation
the context of specific C-terminal amino acids, whereas of the MAP kinase pathway by the EGFR, possibly
PTB domains commonly bind phosphorylated peptide through a dominant-negative effect (O’Bryan et al.,
1998). Most work on Shc functions in the nervous system
has analyzed the role of ShcA in signaling by TrkA in6 To whom correspondence should be addressed (e-mail: pawson@
nerve growth factor–stimulated PC12 cells. ShcA bindsmshri.on.ca).
7 These authors contributed equally to this work. through its PTB domain to the Tyr490 TrkA autophos-
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Figure 1. Comparison of Mouse Shc Adaptor Proteins
Predicted amino acid sequences of three mouse Shc family proteins were aligned by the clustalW program. Amino acids that are identical
or that show conservative substitution are shown in black and gray boxes, respectively. Putative initiating methionines are underlined. PTB
and SH2 domains are boxed, and tyrosines in Grb2 binding sites are marked by filled triangles.
phorylation site, resulting in ShcA phosphorylation, for- 1996b; Pelicci et al., 1996). However, the N-terminal se-
quence and, thus, the identity of the ShcB protein hasmation of an ShcA-Grb2-Sos1 complex, Ras activation,
and stimulation of the MAPK and PI3K pathways (Basu been unclear. By screening several cDNA libraries, a
mouse ShcB cDNA was isolated that encodes an ex-et al., 1994; Stephens et al., 1994; Dikic et al., 1995).
These ShcA-mediated pathways have been implicated tended proline-rich sequence of z120 amino acids
in both survival and neurite outgrowth in PC12 cells. N-terminal to the PTB domain, including possible Met
Since they have very similar domain structures, ShcB initiation codons and two PXPXXP motifs that might bind
and ShcC may regulate pTyr signaling in neuronal cells SH3 domains (Figure 1). Within this N-terminal segment,
in a similar fashion to ShcA. Indeed, ShcC apparently residues 40–123 are 53% identical to the most N-termi-
mediates a TrkA signal in cultured dorsal root ganglion nal sequence of a human ShcB cDNA product lacking
(DRG) cells (Ganju et al., 1998). an initiation codon (Nakamura et al., 1998). From the
To investigate the roles of Shc proteins in the mamma- PTB domain, the amino acid sequence of the mouse
lian nervous system, we have made loss-of-function mu- protein is 86% identical to human ShcB and 94% identi-
tations in the relevant genes. Mouse embryos deficient cal to rat ShcB. The PTB and SH2 domains of ShcB are
for ShcA die during early embryogenesis (Lai and Paw- z70% identical to the corresponding domains in ShcA
son, 2000), and we have therefore focused our analysis and ShcC. The central CH1 region has three conserved
of the nervous system on mice lacking ShcB or ShcC. motifs. One of these (residues 422–435) corresponds to
Our results indicate that signaling by ShcB and ShcC is an element in ShcA that binds adaptins (Okabayashi et
required for the development of subpopulations of both al., 1996), while the other two CH1 motifs contain the
sympathetic and sensory neurons in vivo. sequences YYNS and YVNT, both of which have the
potential to bind Grb2 when phosphorylated.
Results
Targeted Disruption of the ShcB and ShcC Loci
and Generation of ShcB/ShcC Null MiceCloning of a Full-Length Mouse ShcB cDNA
Previous work has identified human, rat, and mouse Clones that cover z30 kb of the ShcB genomic se-
quence were isolated from a murine 129/Sv library. TheShcB cDNAs (Nakamura et al., 1996; O’Bryan et al.,
ShcB and ShcC Functions in the Nervous System
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Figure 2. Targeting of the Mouse ShcB Gene in R1 ES Cells
(A) Targeting the ShcB locus. The first seven exons are shown as vertical closed boxes (ex 1–7) with the 59 noncoding region of exon 1 shown
as an open box. Crossovers between the endogenous ShcB locus and the targeting vector are indicated by broken lines, the IRES-LacZ
cassette and the PGK1-Neor cassette (neor) by open boxes, and the HSV-TK cassette (TK) by a hatched box. Cleavage sites for restriction
endonucleases BamHI (B), EcoRI (E), XhoI (Xh), HindIII (H), NotI (No), and NdeI (Nd) are shown. Two probes used to identify homologous
recombination events are indicated by small horizontal lines. Expected sizes of bands detected by Southern blot analysis from wild-type (wt)
and targeted genes (T) are indicated by arrows.
(B) Southern blot analysis of G418r-GancR ES cell clones. Genomic DNAs were digested with BamHI or HindIII as indicated and submitted
to Southern blot analysis using the 39 probe or the 59 probe, respectively. The wild-type DNA (wt) shows a 6.5 kb fragment using the 39 probe
and an 11.5 kb fragment using the 59 probe, whereas targeted DNA (T) shows a 3.5 kb fragment with the 39 probe and a 4.1 kb fragment with
the 59 probe, as indicated in (A). ShcB genotypes are indicated above.
(C) Southern blot analysis of ShcB recombinant mice. Tail DNA of mice from an ShcB1/2 cross was examined by Southern blot analysis using
the 39 probe. The wild-type DNA (wt) shows a 6.5 kb fragment, whereas targeted DNA (T) shows a 3.5 kb fragment. ShcB genotypes are as
indicated.
first seven ShcB coding exons encode the N-terminal polypeptide from brain lysates of wild-type mice, as
detected by immunoblotting with anti-ShcB-GP, whichupstream region and the entire PTB domain, and the
intron–exon boundaries are similar to ShcA. was undetectable in ShcB2/2 brain lysates (Figure 3B).
In vitro translation of the ShcB cDNA yielded a proteinTo disrupt the ShcB locus, an IRES-LacZ sequence
followed by a Neor cassette was inserted at an NdeI site that comigrated with the 68 kDa polypeptide and was
recognized by anti-ShcB antibodies (Figure 4A). Thesein exon 5, in the middle of the sequence encoding the
PTB domain (Figures 1 and 2A). This insertion should results suggest that ShcB encodes a 68 kDa protein
(p68ShcB), which is disrupted by the targeted mutation.terminate translation within the PTB domain. Germline
transmission of the mutant allele was obtained from two Similar to the ShcB mutation, we introduced a muta-
tion into the mouse ShcC gene, through the incorpora-independent ES cell clones (1F11 and 2C5). Heterozy-
gous mice developed normally and were crossed to tion of an IRES-LacZ cassette (our unpublished data).
Although the mutant locus does not encode detectableobtain animals homozygous for the ShcB mutation,
which were born at the expected Mendelian ratio (Fig- ShcC protein (Figure 3C), ShcC2/2 animals are viable. In
contrast to ShcB, the inserted IRES-LacZ cassette isures 2B and 2C). LacZ staining of embryos and adult
ShcB mice did not reveal b-galactosidase activity, indi- expressed in ShcC1/2 and ShcC2/2 mice (Figures 5O–5R
and 7A–7C). Neither ShcC nor Grb2 are grossly upregu-cating that the inserted IRES-LacZ cassette is not active.
To identify the ShcB product, we raised two different lated in mice lacking ShcB, nor is Grb2 upregulated in
ShcC2/2 mice (Figure 3C).polyclonal antisera using GST fusion proteins containing
the CH1 or SH2 regions of the ShcB protein (designated To test whether ShcB and ShcC have redundant roles,
we intercrossed ShcB and ShcC null mutants to produceanti-ShcB-GP and anti-ShcB-SH2, respectively). A 68
kDa protein, identified in blots of wild-type brain lysate ShcB2/2ShcC2/2 double homozygous null mutants.
These mice were viable, fertile, and born at the expectedusing anti-ShcB-GP antibody, was reduced in ShcB het-
erozygotes and missing from ShcB2/2 mice (Figure 3A). Mendelian ratio. Adult ShcB/ShcC double null mutants
appeared normal with respect to all internal organs andSimilarly, both antisera immunoprecipitated a 68 kDa
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Figure 3. Shc Expression in Wild-Type and Mutant Mice
(A) Whole-brain lysates from 4-week-old mice were analyzed by Western blotting with ShcB-GP antiserum, using two mice of each ShcB
genotype from the same litter.
(B) Brain lysates as in (A) were precipitated with either ShcB-GP or ShcB-SH2 antibodies and analyzed by immunoblotting with anti-
ShcB-GP.
(C) ShcC and Grb2 are not upregulated in ShcB mutants. Brain lysates from 4-week-old mice were analyzed with ShcC or Grb2 antibodies,
using two mice of each ShcB genotype from the same litter. Lysate from a 4-week-old ShcC2/2 mouse brain was included (lane 7).
(D) Tissue lysates from 4-week-old mice were immunoprecipitated with anti-ShcB, then analyzed by immunoblotting with ShcB antibodies.
Samples are brain (lane 1), spinal cord (lane 2), thymus (lane 3), lung (lane 4), heart (lane 5), liver (lane 6), spleen (lane 7), stomach (lane 8),
intestine (lane 9), kidney (lane 10), testis (lane 11), and skeletal muscle (12). The position of ShcB is shown with an arrowhead.
(E) Mouse brain lysates prepared from E12 (lane 1), E15 (lane 2), P0 (lane 3), 2-week-old (lane 4), 4-week-old (lane 5), and 12-week-old (lane
6) animals were analyzed by Western blotting for ShcB. A brain lysate from a 4-week-old ShcB2/2 mouse was also analyzed (lane 7).
(F) The lysates in (E) were analyzed by Western blotting with anti-ShcC (lanes 1–6). Brain lysate from a 4-week-old ShcC2/2 mouse was also
examined (lane 7).
(G) Antisense ShcA RNA in situ hybridization of lumbar DRG at E11.5.
(H) Antisense ShcB RNA in situ hybridization of lumbar DRG at E11.5.
(I) Antisense ShcA RNA in situ hybridization of lumbar DRG at E13.5.
(J) Antisense ShcB RNA in situ hybridization of lumbar DRG at E13.5.
(K) Western blot of whole-brain and DRG lysates probed for ShcB. Lane 1, 100 mg whole-brain extract from adult ShcB1/2ShcC1/2 mice; lane
2, 100 mg whole-brain extract from adult ShcB2/2ShcC2/2 mice; lane 3, 60 mg total protein lysates from E18 T12-L4 DRG. Note that ShcB is
enriched within the DRG relative to whole brain.
exhibited no overt signs of neurologic or behavioral ab- ies from transfected cells (Figures 4B, lanes 2 and 4;
and 4C, lane 8). After stimulation with EGF, several pTyr-normalities on either 129/SvCp or mixed genetic back-
grounds. containing proteins were immunoprecipitated with ShcB
antibodies (Figures 4C and 4D, lanes 4 and 8), including
a 72 kDa protein corresponding to tagged ShcB and theThe ShcB Protein Mediates
Phosphotyrosine Signaling activated EGFR. In addition, ShcB coprecipitated with
Grb2 following EGF stimulation (Figure 4E, lane 8).We investigated the potential involvement of the ShcB
protein in tyrosine kinase signaling by expressing the
mouse ShcB cDNA in COS-1 cells as a fusion protein Tissue Distribution of ShcB and ShcC
To analyze ShcB tissue distribution, lysates of 8-week-with a C-terminal Myc epitope tag, which adds 38 amino
acids. A protein of the expected size (72 kDa) was immu- old mouse tissues were immunoprecipitated with ShcB
antibody and blotted with a second ShcB antibody.noprecipitated by both anti-ShcB and anti-myc antibod-
ShcB and ShcC Functions in the Nervous System
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Figure 4. Growth Factor–Induced Phosphorylation and Interactions of ShcB in Cultured Cells
(A) ShcB cDNA encodes a full-length protein. Protein samples synthesized from a ShcB cDNA using an in vitro transcription/translation system
(lanes 1–3) were immunoprecipitated by ShcB-GP antibody and then immunoblotted with anti-ShcB-GP. Plasmids used are pBluescript SK2
alone (lane 1), a partial ShcB DNA clone 92-12 starting from amino acid position 84 (lane 2), and the full-length ShcB cDNA starting from the
first methionine (lane 3). For comparison, whole-brain lysates (lanes 6 and 7), as well as lysates precipitated by ShcB-GP antibody (lanes 4
and 5) from wild-type (lanes 4 and 6) or ShcB2/2 (lanes 5 and 7) mice, were analyzed.
(B) Full-length mouse ShcB cDNA in the pCDNA3.1(2)Myc-HisA vector (lanes 2 and 4) or empty vector (lanes 1 and 3) was transfected into
COS-1 cells. Lysates were immunoprecipitated with anti-ShcB-GP or anti-myc antibodies and analyzed by Western blotting using ShcB-GP
antibody. Lysate from a wild-type mouse is included in lane 5.
(C–E) Triplicate filters were analyzed by immunoblotting with anti-ShcB (C), anti-pTyr (4G10) (D), or anti-Grb2 (E). In each case, epitope-tagged
ShcB cDNA (ShcB-myc; lanes 3, 4, 7, and 8) or empty vector (vector; lanes 1, 2, 5, and 6) was transfected into COS-1 cells and stimulated
with either EGF (plus symbol; lanes 2, 4, 6, and 8) or was untreated (minus symbol; lanes 1, 3, 5, and 7). Total cell lysates (lanes 1–4) or anti-
ShcB-GP immunoprecipitates (lanes 5–8) were separated and subjected to immunoblotting.
(D) The positions of the phosphorylated EGF receptor (open triangle) and the ShcB protein (solid triangle) are indicated.
p68ShcB was primarily detected in brain and spinal cord tissue lysates (and endogenous b-galactosidase activ-
ity; see below) demonstrated that ShcC was expressed(Figure 3D) and more faintly in lung, heart, and stomach,
which may reflect neural innervation of these tissues. exclusively in neural tissue, consistent with previous
mRNA studies (Nakamura et al., 1998). Expression was lowTo examine ShcB expression during development, CNS
extracts were prepared from embryonic and postnatal during embryonic development and became strongly
upregulated within the CNS around the time of birthmice and immunoblotted with ShcB antibodies (Figure
3E). P68ShcB can be observed in the CNS at embryonic (Figure 3F). ShcC expression continued to increase dur-
ing postnatal development, reaching maximal levels byday (E) 12 and shows a modest increase from E15 until
postnatal day 1 (P1) (Figure 3E). To pursue the pattern 6–8 weeks postnatal.
of ShcB expression in the developing CNS/PNS, we
used RNA in situ hybridization analysis from E11.5 to Analysis of the Sensory System
in ShcB/ShcC Null MiceE16.5. These results indicate that ShcB is expressed
broadly throughout the developing embryo but is partic- Several RTKs that bind Shc function in specific popula-
tions of sensory and sympathetic neurons (Fagan et al.,ularly strong within developing peripheral ganglia such
as the DRG and superior cervical ganglion (SCG). The 1996; Pinon et al., 1996; Conover and Yancopoulos,
1997). We therefore examined these populations inexpression of ShcB in developing lumbar DRG is shown
at E11.5 and E13.5 (Figures 3H and 3J; see also Figures ShcB, ShcC, and ShcB/ShcC null mutants. For the sen-
sory nervous system, we focused on L4 DRG, as these5A and 5B). In addition, Western analysis of DRG from
the lower thoracic and lumbar spinal segments (T12-L4) ganglia contain all major classes of sensory neurons and
have previously been analyzed in RTK mutants (Snider,at E18.5 identified strong expression of p68ShcB. Thus,
within the developing DRG, ShcB and ShcC (see below) 1994). We observed substantial expression of both ShcB
(Figures 3H, 3J, and 3K) and ShcC (as indicated byare strongly expressed, whereas ShcA mRNA could not
be detected (Figures 3G and 3I). b-galactosidase activity; see Figures 5O–5R) within the
DRG, from E11 to adulthood. The pattern of ShcC ex-The ShcC gene encodes two protein isoforms of 53
and 67 kDa (O’Bryan et al., 1996b). Analysis of whole- pression appeared mosaic within both the DRG and a
Neuron
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Figure 5. Analysis of Sensory Neurons in ShcB/ShcC Null Mice
(A) Bright-field view of E13.5 DRG showing cellular composition.
(B) Dark-field view of same section hybridized with antisense ShcB RNA probe, showing pattern of silver grain deposition over section. Note
that ShcB is expressed within the vast majority of DRG neurons.
(C) Comparison of the total number of axons observed within the L4 ventral root of ShcB/ShcC mice. For each of the graphs, genotypes are
as follows: ShcB1/2ShcC1/2, wt; ShcB2/2ShcC2/2, BC; ShcB2/2ShcC1/1, B; and ShcB1/1ShcC2/2, C. Asterisks indicate a significant difference
from the control group (p , 0.05); error bars are 6 SEM; n $ 5 for each genotype. Values obtained for ShcB1/1ShcC1/2, ShcB1/2ShcC1/1,
and ShcB1/2ShcC1/2 mice did not vary significantly from wild-type controls of similar genetic background.
(D–F) Comparison of the total numbers of immunopositive neurons within the L4 DRG of adult (8-week-old) ShcB/ShcC mice. (D), TrkA; (E),
IB4 (isolectin B4); and (F), neurofilament heavy chain.
(G–J) Photomicrographs of representative adult L4 DRG cross sections stained for TrkA; scale bar equals 100 mm. (G), ShcB1/2ShcC1/2; (H),
ShcB2/2ShcC2/2; (I), ShcB2/2ShcC1/1; and (J), ShcB1/1ShcC2/2.
ShcB and ShcC Functions in the Nervous System
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Table 1. Analysis of Superior Cervical and Dorsal Root Ganglia in ShcB/ShcC Null Mice
DRG cell number (L4–adult): [1/2,1/2] [2/2,2/2]
3,447 6 191 2,151 6 164*
Analysis of SCG at E13.5: [1/2,1/2] [2/2,2/2]
TUNEL-positive cells 275 6 19 256 6 22
BrdU-positive cells 476 6 39 432 6 45
SCG cell count: [1/2,1/2] [2/2,2/2]
E13.5 12,456 6 636 11,856 6 586
pnd 0 18,010 6 847 13,720 6 734*
pnd 56 9,981 6 754 6,726 6 572*
pnd 56 [2/2,1/1], [1/1,2/2] 8,917 6 672 8,234 6 612
Serial sections of SCG and DRG ganglia were analyzed for total cell number. SCG ganglia were also analyzed for numbers of proliferating
and apoptotic cells at E13.5. Cellular proliferation was assessed by incorporation of BrdU, while apoptosis was assessed by TUNEL assay.
Total cell numbers were determined from thionin-stained serial sections cut in parallel with two additional series. Cells were counted if they
contained a clear nucleus and nucleolus and were assessed by the method of physical dissector (lookup/reference frame interval, 30 mm;
section thickness, 5 mm). Numbers are shown without correction for split nucleoli. Results are shown for ShcB1/2ShcC1/2 5 [1/2,1/2] and
Shc2/2ShcC2/2 5 [2/2,2/2]. For each analysis, n $ 6 animals from each group. Results obtained for ShcB1/1, ShcB1/2, ShcC1/1, ShcC1/2,
and wild-type littermates were not found to vary significantly from those obtained for ShcB1/2ShcC1/2 mice; n 5 6 for [1/2,1/2] group, n 5
7 for [1/1,2/2] and [2/2,1/1] groups, and n 5 9 for [2/2,2/2] group.
* Indicates significant difference from control group (p # 0.05).
number of other sensory ganglia, with the percentage and these reductions are not observed in mice lacking
ShcC alone. Cross sections of L4 DRG stained for eitherof Shc1 neurons varying substantially between neurons
of a given group during development. We have detected TrkA or IB4 are shown for wild-type, ShcB/ShcC, ShcB,
and ShcC mutants in Figures 5G–5J and 5K–5N, respec-no gross developmental abnormalities in ShcC2/2 mice.
Consistent with this, although .80% of neurons in the tively. In contrast, no reduction in NFH1 neurons was
observed in any of the ShcB/ShcC mutants (Figure 5F).vestibular and spiral ganglia express ShcC, these struc-
tures appeared normal in ShcC (and ShcB/ShcC) null These data demonstrate that loss of ShcB but not ShcC
results in a reduction but not complete elimination ofmice (data not shown).
To examine the effects of ShcB/ShcC ablation on sen- peptidergic and nonpeptidergic neurons associated
with nociceptive function. In addition, these data dem-sory innervation, 1 mm semithin cross sections from the
L4 dorsal root of 8- to 9-week-old ShcB, ShcC, and onstrate that ShcC cannot functionally compensate for
the loss of ShcB in nociceptive neurons. To understandShcB/ShcC mutants were examined. Counts of total
myelinated axons within the dorsal root were reduced the inability of ShcC to compensate for ShcB in this
nociceptive population, we examined the expression ofz32% in both ShcB2/2 and ShcB2/2ShcC2/2 mice,
whereas ShcC2/2 mice exhibited no significant loss of ShcC with respect to TrkA and IB4. As shown in Figures
5O, 5P, 5Q, and 5R, respectively, ShcC (as monitoredmyelinated axons (Figure 5C). Similarly, cell counts of
L4 DRG from 8- to 9-week-old ShcB2/2ShcC2/2 and by b-galactosidase activity) does not strongly colocalize
with either TrkA or IB4. Analysis of 300 TrkA1 neuronsShcB1/2ShcC1/2 mice demonstrated a reduction of
z38% (Table 1). Thus, both ShcB2/2 and ShcB2/2ShcC2/2 demonstrated that ShcC colocalized with this popula-
tion in only 15% of cases. Similarly, ShcC colocalizedmice exhibit a similar and substantial loss of sensory
neurons. with only 8% of IB41 neurons. In contrast, z60% of
ShcC1 neurons coexpress NFH. Thus, ShcC is not ex-To determine if the loss of sensory axons in ShcB2/2
ShcC2/2 and ShcB2/2 mice reflects the loss of a specific pressed in the large majority of DRG neurons that are
affected in ShcB2/2 mice.class of neurons, DRG sensory populations were exam-
ined in greater detail. ShcB is expressed within virtually These results demonstrate that loss of ShcB primarily
affects a subpopulation of neurons commonly associ-all DRG neurons at E13.5 (Figures 5A and 5B). The num-
bers of TrkA1, IB41, and NFH1 neurons were therefore ated with cutaneous nociceptive function. To determine
the effects of ShcB/ShcC deletion on cutaneous in-determined in 8-week-old L4 DRG for ShcB, ShcC, and
ShcB/ShcC null mice, as shown in Figures 5D, 5E, and nervation, we examined the T13 dorsal cutaneous
nerve (DCN). Typical cross sections of the DCN from5F, respectively. Loss of ShcB results in a substantial
reduction (.50%) in the numbers of both TrkA1 and ShcB1/2ShcC1/2 and ShcB2/2ShcC2/2 mice are shown
in Figures 6A and 6B, respectively. Similar to the L4IB41 neurons. The additional loss of ShcC in the absence
of ShcB does not exacerbate these neuronal losses, DRG, there is a significant reduction in axon numbers
(K–N) Photomicrographs of adult L4 DRG cross sections stained for IB4; scale bar equals 100 mm. (K), ShcB1/2ShcC1/2; (L), ShcB2/2ShcC2/2;
(M), ShcB2/2ShcC1/1; and (N), ShcB1/1ShcC2/2.
(O–R) Photomicrographs of adult L4 DRG cross sections showing the distribution of ShcC (LacZ, arrows) relative to TrkA; scale bar represents
100 mm.
(Q–R) Cross sections showing the distribution of ShcC (LacZ, arrows) relative to IB4; scale bar equals 50 mm.
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Figure 6. Analysis of Sensory Axons in ShcB/ShcC Mutants
(A) Photomicrograph of a cross section of adult ShcB1/2ShcC1/2 T13 DCN.
(B) Similar view of the DCN from an ShcB2/2ShcC2/2 mutant. Scale bar equals 30 mm.
(C) Comparison of total number of axons observed within the T13 DCN of adult ShcB/ShcC mice.
(C–F) For each graph, genotypes are as follows: ShcB1/2ShcC1/2, wt; ShcB2/2ShcC2/2, BC; ShcB2/2ShcC1/1, B; and ShcB1/1ShcC2/2, C. Asterisks
indicate a significant difference from the controls (p , 0.05); error bars are 6 SEM; n $ 6 for each genotype.
(D) Analysis of large-caliber, thickly myelinated (predominantly Ab) axons of the DCN.
(E) Analysis of small-caliber, thinly myelinated (predominantly Ad) axons of the DCN.
(F) Analysis of small-caliber, unmyelinated (predominantly C fiber and sympathetic) axons of the DCN.
(G–J) EM photomicrographs of thin sections of the DCN of ShcB/ShcC mice. (G), ShcB1/2ShcC1/2; (H), ShcB2/2ShcC2/2; (I), ShcB2/2ShcC1/1;
and (J), ShcB1/1ShcC2/2. Note the reduction in unmyelinated axons in ShcB2/2ShcC2/2 and ShcB2/2ShcC1/1 nerves. Scale bar equals 5 mm.
within the T13 DCN of ShcB and ShcB/ShcC null mice observed in ShcB mice is a direct result of the loss of
sensory neurons rather than defects in axon outgrowthbut not ShcC null mutants (Figure 6C). Combined with
analysis of the DRG, this suggests that the axonal loss or pathfinding. In addition to the reduction in axon num-
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ber, cross-sectional area of the DCN was reduced in roles within this neuronal population. Preganglionic sym-
pathetic innervation appears normal in ShcB2/2ShcC2/2both ShcB2/2ShcC2/2 (8838 6 382 mm2; n 5 6) and
ShcB2/2 (9922 6 421 mm2; n 5 6) mice compared to null mice (Figures 7F and 7G), and several efferent
targets of the SCG in adult ShcB2/2ShcC2/2 mice wereShcB1/2ShcC1/2 (17,237 6 567 mm2; n 5 7) and ShcC2/2
(14,374 6 677 mm2; n 5 8) mice. histologically normal (data not shown), suggesting that
the Shc-dependent cell loss occurs in a cell autono-Within the DCN, three basic axon morphologies can
be distinguished, which can largely be related to a par- mous manner. Sympathetic neurons that survived in
ShcB2/2ShcC2/2 adult mice exhibited no significant dif-ticular class of sensory neurons. Large-caliber, thickly
myelinated axons represent predominantly Ab fibers; ference in somal area (ShcB1/2ShcC1/2, 387.1 6 29 mm2;
ShcB2/2ShcC2/2, 407.3 6 31 mm2; n 5 60/group).smaller caliber, thinly myelinated axons largely repre-
sent Ad fibers; and small-caliber, unmyelinated axons To determine when this SCG neuronal loss occurs
during development, SCG of ShcB/ShcC null mutantsrepresent C fibers and a population of sympathetic fi-
bers. The axonal reduction in the T13 DCN of ShcB and were examined at E13.5 and P0. Total neuronal num-
bers, as well as numbers of TUNEL1 and BrdU1 cells inShcB/ShcC null mutants is not evenly distributed with
respect to axon class (Figures 6D–6F). Significant reduc- the SCG of E13.5 ShcB1/2ShcC1/2 and ShcB2/2ShcC2/2
mice, did not differ significantly (Table 1). Thus, the re-tions in axonal number occur within both large caliber
cutaneous and unmyelinated axons. No significant re- duction in SCG neurons in ShcB2/2ShcC2/2 mice ap-
pears to occur subsequent to E13.5, suggesting a lossduction in small-caliber, thinly myelinated axons was
observed in any of the ShcB/ShcC mutants. As shown of postmitotic neurons rather than a defect in neurogen-
esis. As the peak period of programmed cell death withinin the EM photomicrographs (Figures 6G–6J), the DCNs
of ShcB1/2ShcC1/2 and ShcC2/2 mice exhibit greater num- the SCG occurs during the early postnatal period (Crow-
ley et al., 1994; Fagan et al., 1996), we examined thebers of unmyelinated axons than do those of ShcB2/2
or ShcB2/2ShcC2/2 mice. Thus, deletion of ShcB results SCG of ShcB1/2ShcC1/2 and ShcB2/2ShcC2/2 mice at
P0. ShcB2/2ShcC2/2 mice exhibit a reduction in totalin the loss of a subpopulation of both large-caliber cuta-
neous afferents and unmyelinated axons, while loss of SCG number at P0, which is of similar magnitude to that
observed at P56 (Table 1). In addition, ShcB2/2ShcC2/2ShcC does not affect DCN axons, either alone or in
combination with ShcB. Similar to the DRG analysis, mice undergo a normal decline in SCG neurons between
P0 and P56. Thus, within sympathetic neurons of thethese data suggest that ShcB is involved in the develop-
ment and/or maintenance of a subpopulation of neurons SCG, ablation of ShcB and ShcC results in the loss of
a subpopulation of postmitotic SCG neurons during theinvolved in nociceptive function, as well as low-thresh-
old mechanoceptors. latter phase of embryonic development (E15–P0).
DiscussionEffects of ShcB/ShcC Mutation
on the Sympathetic System
ShcB and ShcC are docking proteins, primarily ex-Neurons of the SCG represent a largely homogeneous
pressed within the nervous system, that can functiongroup of sympathetic neurons, which have been well
downstream of RTKs such as Trk family members andcharacterized for their growth factor responsiveness
c-Ret. To address their biological functions, we haveand RTK expression (Barbacid, 1994; Francis and Lan-
introduced null mutations into the murine ShcB anddis, 1999). In the postnatal period, survival of these neu-
ShcC genes. Analysis of thionin and solochrome cya-rons depends upon TrkA signaling through binding of
nine-stained serial sections of ShcB, ShcC, and ShcB/NGF and NT-3 (Fagan et al., 1996). Given the reduction
ShcC null mutants revealed no overt neuroanatomicalin TrkA-dependent neurons that we observed in the
abnormalities within the CNS. ImmunohistochemicalDRG, we examined the effects of ShcB/ShcC deletion
staining for several neuronal markers (p75, tyrosine hy-on this population of sympathetic neurons. Western
droxylase, and TrkA) within the CNS of ShcB2/2ShcC2/2analysis of early postnatal SCG lysates identified ShcB
mice was also comparable to that of wild-type lit-expression (data not shown), and in situ RNA hybridiza-
termates, as was their pattern of ShcC-directed b-galac-tion analysis demonstrated a high level of ShcB expres-
tosidase activity (data not shown). However, analysission within SCG neurons (Figure 7F). In addition, ShcC
of sensory and sympathetic populations demonstratesis strongly expressed within migrating neural crest cells
that ShcB plays a unique role in the survival of sensory(Figure 7A) and is present in a high percentage of SCG
neurons and acts together with ShcC in supporting sym-neurons from the time of ganglion formation through
pathetic development/survival. Our data suggest thatadulthood (Figures 7B and 7C). ShcB2/2ShcC2/2 null
ShcB/ShcC are important in mediating survival signalsmice do not exhibit overt signs of sympathetic distur-
from RTKs such as TrkA.bance, and their SCG neurons express sympathetic
markers such as tyrosine hydroxylase (Figures 7D and
7E) and TrkA in a normal fashion (data not shown). How- Role of ShcB and ShcC in Sensory
Neurons In Vivoever, counts of SCG neurons in ShcB/ShcC double mu-
tants indicate a significant loss (z33%) of SCG neurons No gross differences in auditory, olfactory, vestibulo-
cochlear, or visual functions were observed in ShcB,by 8 weeks postnatal (Table 1). Interestingly, these ef-
fects are not observed in either ShcB2/2 or ShcC2/2 mice ShcC, or ShcB/ShcC mice, despite prominent expres-
sion of ShcC in a number of sensory ganglia. Responses(Table 1). Thus, in contrast to sensory neurons, ShcB
and ShcC are coexpressed in the large majority of SCG to thermoceptive, nociceptive, and mechanoceptive
stimuli were also comparable to controls on gross analy-neurons and appear to possess functionally redundant
Neuron
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Figure 7. Analysis of Sympathetic System of ShcB/ShcC Mice
(A–C) Examples of ShcC expression, as measured by b-galactosidase activity. Scale bars equal 500 mm.
(A) ShcC expression at E10.5, arrows denote migrating neural crest cells.
(B) SCG whole mount (arrow) demonstrating ShcC expression at P56.
(C) Cross section of P56 SCG showing ShcC expression. Samples shown were derived from ShcB1/1ShcC1/2 animals.
(D–G) Horizontal tissue sections oriented as follows: rostral (top), caudal (bottom), cranial midline (right).
(D) Staining for tyrosine hydroxylase in the SCG of an ShcB2/2ShcC2/2 embryo at E13.5. Scale bar equals 100 mm.
(E) In situ analysis of ShcB in the SCG. Sagittal section containing the SCG in a wild-type mouse probed with antisense ShcB RNA probe at
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sis. However, among sensory neurons of the L4 DRG, tional class, suggesting that docking proteins such as
ShcB are selective with respect to neuronal RTK sig-ShcB2/2 mice exhibit a significant reduction in the num-
ber of TrkA1 and IB41 neurons and small-caliber axon naling.
The GDNF receptor c-Ret binds Shc proteins and isfibers. The additional loss of ShcC does not increase
this neuronal loss, and ShcC is not expressed in the also expressed in a large population of DRG sensory
neurons. It is therefore possible that the ShcB/ShcCvast majority of TrkA1 or IB41 neurons in the DRG. The
survival of specific subpopulations of both peptidergic mutations influence c-Ret signaling. Null mutations in
c-Ret and GDNF family ligands or coreceptors result inand nonpeptidergic DRG neurons is therefore uniquely
dependent upon ShcB. IB41 neurons that undergo a significant sensory reductions in addition to gut, kidney,
and other defects (Moore et al., 1996; Pichel et al., 1996;reduction in ShcB2/2 mice are GDNF dependent and do
not express Trk receptors in the adult (Bennett et al., Enomoto et al., 1998; Heuckeroth et al., 1999). Histologic
examination of the duodenum and kidney of adult ShcB/1996; Molliver et al., 1997). However, these neurons do
express TrkA during embryonic development, and this ShcC null mice identified no significant abnormalities,
and these animals do not exhibit observable motor neu-population is lost in mice lacking TrkA (Silos-Santiago
et al., 1995; Molliver et al., 1997). TrkA1 and IB41 neurons ron loss. Despite this, it is possible that the loss of
IB41 neurons within the DRG of ShcB2/2 mice reflectsprimarily represent a population of small-caliber, unmy-
elinated axons that relay cutaneous nociceptive infor- impaired c-Ret signaling, although this might equally
reflect a developmental requirement for TrkA signaling,mation (Molliver et al., 1997), and, indeed, ShcB and
ShcB/ShcC null mice show similar levels of axonal loss as indicated above. In contrast to their similarities to
TrkA null mutants, the phenotype of ShcB/ShcC nullin T13 dorsal cutaneous nerve. While we did not resolve
cutaneous axons into functional groups by electrophysi- mice differs in several significant respects from that
observed in TrkC null mice.ologic criteria, a significant correlation has previously
been described between axon morphology and func- The phenotype of ShcB/ShcC null mice also differs
significantly from that of TrkB null mutants. Most nota-tional class (Ab, Ad, and C fiber/sympathetic) (Airaksinen
et al., 1996; Kinkelin et al., 1999; Stucky et al., 1999). bly, we do not observe significant loss of Ad fibers in
ShcB/ShcC null mice. The Ad (D hair mechanoceptive)The axonal loss in ShcB mutants affects small-caliber,
unmyelinated axons (C fibers and sympathetic axons) neurons are dependent upon NT-3/TrkB signaling (Air-
aksinen et al., 1996; Fundin et al., 1997). In addition, aand large-caliber, thickly myelinated axons (largely Ab
axons) to a much greater extent than small-caliber my- mutation in TrkB that abolishes the PTB domain binding
site results in an almost total loss of D hair mechanocep-elinated axons (predominantly Ad axons).
While we have not defined the RTKs that couple to tors and a loss of neurons within the vestibular ganglion
(albeit at a somewhat reduced level compared to TrkBShcB in sensory neurons, disruption of TrkA signaling
may contribute to the ShcB mutant phenotype. Consis- null mice) (Minichiello et al., 1998). Neither of these ef-
fects is evident in ShcB/ShcC null mutants, indicatingtent with the loss of TrkA1 neurons in ShcB null mice,
substantial losses of both unmyelinated small-caliber C that either ShcB/ShcC do not function downstream of
TrkB or that other docking proteins can compensate forand large-caliber myelinated (Ab) axons are observed.
Both NGF and NT-3 signaling may support Ab subpopu- their loss.
lations in vivo (Diamond et al., 1992; Airaksinen et al.,
1996; Stucky et al., 1999), while C fibers appear to de- ShcB and ShcC Have Overlapping Functions
in the Sympathetic Nervous Systempend solely on NGF/TrkA (Diamond et al., 1992; Double-
day and Robinson, 1992). Intriguingly, we do not observe Within the SCG, adult ShcB2/2ShcC2/2 mice demon-
strate significant reductions (.35%) in neuronal num-a substantial loss of Ad axons within the cutaneous
nerve (although this population is reduced 15%–18% in ber, whereas mice lacking ShcB or ShcC alone do not.
In contrast to sensory neurons, there is widespreadShcB2/2 mice), which would be expected in the event
of a significant loss of TrkA-dependent Ad fibers (AM- coexpression of ShcB and ShcC in SCG neurons during
embryonic and postnatal development, and these pro-nociceptors; however, see below). In addition, similar
to TrkA2/2 mice, the spiral and vestibular ganglia as well teins appear to play redundant roles in the survival of
at least a subpopulation of these cells.as axonal counts of the L4 motor root are comparable
to wild type. Thus, while loss of ShcB appears to affect Null mutations of several RTKs that interact with Shc
family members have been characterized for effects onTrkA-dependent signaling in some sensory populations,
it is dispensable in others. Even within affected popula- SCG development and survival (Snider, 1994; Wyatt et
al., 1997). Loss of either TrkA (Smeyne et al., 1994; Fagantions, the loss of ShcB does not affect an entire func-
E15.5 is shown, with adjacent (70 mm lateral) section stained for tyrosine hydroxylase. Dotted line, edge of the tubotympanic recess; arrowhead,
junction of the internal and external carotid artery. Scale bar represents 50 mm.
(F) Staining for NADPH diaphorase in preganglionic sympathetic neurons at 9 weeks postnatal in ShcB1/2ShcC1/2 and ShcB2/2ShcC2/2 mice
(cc, central canal; iln, intermediolateral nucleus). Cross sections are taken from the T2 level. Scale bar equals 500 mm.
(G) Light and EM cross sections of the cervosympathetic trunk of ShcB1/2ShcC1/2 and ShcB2/2ShcC2/2 mice. Scale bar equals 12 mm; insets
1 mm.
(H) TUNEL staining within the SCG at E13.5 of ShcB1/2ShcC1/2 and ShcB2/2ShcC2/2 mice. Scale bar represents 100 mm; dotted area represents
SCG.
(I) BrdU labeling within the SCG of ShcB1/2ShcC1/2 and ShcB2/2ShcC2/2 mice at E13.5. Scale bar equals 100 mm. ca, carotid artery; X, inferior
ganglion of the vagus nerve.
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et al., 1996) or c-Ret (Moore et al., 1996) results in a in the survival of specific neuronal classes and also
argue that these proteins are not the sole targets ofvirtual elimination of SCG neurons, while loss of TrkC or
TrkB does not significantly affect SCG neuronal survival neuronal RTK signaling but rather mediate a surprisingly
specific subset of cellular responses to growth factor(Fagan et al., 1996; Conover and Yancopoulos, 1997).
Both NGF and NT-3 can participate in TrkA-dependent stimulation in neuronal cells. This is reminiscent of ShcA,
which plays a selective role in signaling within the car-signaling in SCG neurons (Crowley et al., 1994; ElShamy
et al., 1996; Conover and Yancopoulos, 1997), and GDNF diovascular system of the early embryo (Lai and Pawson,
2000). These data indicate that mammalian Shc proteinsfamily members have been implicated in c-Ret signaling
in the SCG (Creedon et al., 1997; Granholm et al., 1997). are not simply generic components of RTK signaling
pathways but rather can have very specific biologicalOne means of distinguishing the relative effects of
TrkA- versus c-Ret-mediated signaling in SCG neurons functions, as also appears to be the case of Drosophila
Shc (DSHC) (Luschnig et al., 2000).is by the temporal pattern of their effects. c-Ret has
actions on developing SCG neurons that largely precede
Experimental Proceduresthose of TrkA (Smeyne et al., 1994; Durbec et al., 1996).
Thus, interference with c-Ret signaling would result in
Construction of ShcB Targeting Vector
neuronal reductions in the SCG evident by E13.5, while ShcB targeting vector was constructed by inserting 3.0 and 1.9 kb
TrkA-mediated effects become noticeable later in devel- fragments around exon 5 of the ShcB gene into pPNT, along with
opment (Durbec et al., 1996; Francis and Landis, 1999). the IRES-LacZ cassette. The linearized vector was electroporated
in the ES cell line R1, and colonies were isolated by selection withLoss of ShcB and ShcC results in the death of a subpop-
G418 and gancyclovir (Nagy et al., 1993). Southern blot analysisulation of postmitotic SCG neurons between E13.5 and
with both 59 and 39 external probes identified 4/300 clones withP0, most probably as a result of a regiospecific loss of
homologous recombination. Germline transmission was as de-
TrkA signaling. Given that a similar degree of neuronal scribed (Nagy et al., 1993).
loss is observed at both P0 and P56 in ShcB2/2ShcC2/2
mice, NT-3- rather than NGF-mediated signaling may Cell Culture
play the dominant role in these effects. COS-1 cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) with 10% fetal bovine serum (PBS). Full-length ShcB cDNAAs in sensory neurons, the loss of ShcB and ShcC
in the expression vector pCR3.1(2)Myc-HisA (Invitrogen) was trans-appears to affect only a subpopulation of sympathetic
fected with Lipofectin (Gibco/BRL). Cells were either harvested 48neurons, perhaps due to functionally redundant signal-
hr after transfection or starved in DMEM/0.5% FBS for 24 hr and
ing proteins. Thus, within this population, substantial then stimulated with 100 ng/ml of EGF (UBI) for 10 min.
interneuronal differences may exist at the level of signal-
ing interactions, which may have important functional SDS-Polyacrylamide Gel Electrophoresis
and Western Blottingconsequences with respect to trophic responsiveness.
Anti-ShcB-GP and anti-ShcB-SH2 antibodies were raised in rabbits
against GST fusions containing the CH1 domain (aa 310–477) or theFunctions of ShcB and ShcC
SH2 domain (aa 475–573) of mouse ShcB. Anti-Grb2 (C21) and anti-
Docking Proteins In Vivo phosphotyrosine (4G10) antibodies were from UBI. Cells were rinsed
The neuronal losses observed in ShcB/ShcC mutants twice with ice-cold PBS and lysed in PLC-lysis buffer (Rozakis-
Adcock et al., 1993). For immunoblotting, lysates containing 50 mgare consistent with the biochemical functions of Shc
protein per lane were applied to gels. For immunoprecipitation, cellproteins observed in cultured neuronal cells, although
lysates containing 1 mg of protein were mixed with 10 ml of anti-these data have been primarily obtained for ShcA. ShcA-
ShcB. Immunoprecipitation and blotting with anti-pTyr antibodiesmediated activation of the MAPK pathway has been
or polyclonal antibodies were as described (van der Geer et al.,
strongly implicated in neural cell differentiation induced 1995).
by NGF (Basu et al., 1994; Obermeier et al., 1994; Ste-
phens et al., 1994). Furthermore, the ability of ShcA to In Vitro Transcription/Translation System
ShcB cDNAs were subcloned into pBluescript SK2 (Stratagene) andstimulate PI3K can contribute to NGF-mediated survival,
used as a template in a coupled TNT reticulocyte lysate systempotentially by suppressing the p53 proapoptotic path-
(Promega).way (Hallberg et al., 1998; Mazzoni et al., 1999). How-
ever, it is evident that Shc proteins are not the only
Tissue Preparation
cytoplasmic effectors of TrkA signaling. SH2-containing Except for b-galactosidase analysis, mice were anesthetized with
enzymes such as phospholipase C-g1 and PI3K can sodium pentobarbital and perfused transcardially with PBS, followed
bind activated TrkA independently of Shc and contribute by 4% paraformaldehyde at 48C. Morphometry samples were post-
fixed for 4 hr in paraformaldehyde at 48C. Nerve segments wereto neurite outgrowth in PC12 cells or guidance of spinal
fixed in 2% glutaraldehyde, 0.1 M PBS at pH 7.2. Samples werenerve growth cones toward NGF (Inagaki et al., 1995;
processed as thin sections or as cryostat or paraffin (5–7 mm) sec-Ming et al., 1999). Furthermore, a number of pTyr dock-
tions (Ausubel, 1991). For cryostat sections, samples were cryopro-
ing proteins with PTB or SH2 domains, including ShcA, tected in 30% sucrose, then frozen in 2-methyl butane, and sections
FRS2, SH2-B, and rAPS (O’Bryan et al., 1996b; Kouhara were obtained using a Leitz cryostat at 2228C. Samples were ana-
et al., 1997; Qian et al., 1998), can recognize neuronal lyzed in a blinded manner.
RTKs and might partially compensate for the loss of
Analysis of Neuronal NumberShcB/ShcC.
The SCG and DRG counts were assessed from serial 5–7 mm paraffinTaken together, the data argue that the ShcB and
sections stained with the appropriate antibody or 0.1% thionin.ShcC docking proteins have specific physiological func-
Counts of these sections were determined by the method of physical
tions in survival of postmitotic mammalian sensory and dissector (Cruz-Orive and Weibel, 1990; Coggeshall and Lekan,
sympathetic neurons. Our results suggest that they 1996) (adults specimens: lookup/reference frame interval, 50 mm;
E13.5 specimens: lookup/reference frame interval, 30 mm). Neuronsfunction as effectors of TrkA, and potentially other RTKs,
ShcB and ShcC Functions in the Nervous System
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